ID   LK2
AC   CVCL_W132
DR   cancercelllines; CVCL_W132
DR   Cosmic; 1609531
DR   GEO; GSM313666
DR   Progenetix; CVCL_W132
DR   Wikidata; Q54902670
RX   PubMed=1892748;
RX   PubMed=15677628;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
RX   PubMed=1892748; DOI=10.1038/bjc.1991.279; PMCID=PMC1977519;
RA   Mistry P., Kelland L.R., Abel G., Sidhar S., Harrap K.R.;
RT   "The relationships between glutathione, glutathione-S-transferase and
RT   cytotoxicity of platinum drugs and melphalan in eight human ovarian
RT   carcinoma cell lines.";
RL   Br. J. Cancer 64:215-220(1991).
//
RX   PubMed=15677628; DOI=10.1093/carcin/bgi032;
RA   Gorringe K.L., Chin S.-F., Pharoah P.D.P., Staines J.M., Oliveira C.,
RA   Edwards P.A.W., Caldas C.;
RT   "Evidence that both genetic instability and selection contribute to
RT   the accumulation of chromosome alterations in cancer.";
RL   Carcinogenesis 26:923-930(2005).
//